GNH USA

Europe — EMA

Metoprolol Tartrate Generics [uk]

GNH USA supplies Metoprolol Tartrate Generics [uk] (Metoprolol Tartrate), a beta blocker for hypertension, angina and heart failure.

Metoprolol Tartrate

Request sourcing

1
Pack/s

What is Metoprolol Tartrate?

Metoprolol Tartrate, the active ingredient in Metoprolol Tartrate Generics [uk], is a beta blocker presented as an oral dosage form for oral use. It is prescribed for hypertension, angina pectoris, post‑myocardial infarction care, heart failure and certain cardiac arrhythmias in adult patients.

GNH USA supplies Metoprolol Tartrate Generics [uk] as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Metoprolol Tartrate used for?

Metoprolol Tartrate is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers systemic blood pressure by reducing cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction: reduces risk of recurrent infarction and improves survival. - Heart failure: improves left‑ventricular function and reduces hospitalisation. - Cardiac arrhythmias: controls heart rate in atrial fibrillation and other supraventricular tachyarrhythmias.

What are the side effects of Metoprolol Tartrate?

Metoprolol Tartrate may cause a range of adverse reactions.

Common Side Effects: - Fatigue or tiredness. - Dizziness or light‑headedness, especially on standing. - Bradycardia (slow heart rate). - Gastrointestinal discomfort such as nausea or abdominal pain.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension with risk of syncope. - Bronchospasm in patients with reactive airway disease.

What precautions apply to Metoprolol Tartrate?

Before initiating therapy, clinicians should consider several safety factors. - Blood pressure monitoring: ensure adequate control and avoid excessive hypotension. - Cardiac function assessment: evaluate for heart block or severe bradycardia. - Respiratory caution: use carefully in patients with asthma or chronic obstructive pulmonary disease. - Dose adjustment: consider renal or hepatic impairment when titrating. - Discontinuation: avoid abrupt withdrawal to prevent rebound hypertension or tachycardia. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Metoprolol Tartrate interact with?

Metoprolol Tartrate can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid): - Verapamil or diltiazem: additive negative‑chronotropic effects may cause severe bradycardia. - Clonidine: abrupt discontinuation after concurrent use can precipitate hypertensive crisis. - Insulin or oral hypoglycemics: β‑blockade may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely): - Diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring. - ACE inhibitors or ARBs: combined therapy can increase risk of hypotension. - NSAIDs: may reduce the antihypertensive efficacy of metoprolol.

Frequently asked questions

What conditions is Metoprolol Tartrate used to treat?+
Metoprolol Tartrate is prescribed for high blood pressure, chest pain due to angina, post‑myocardial infarction care, chronic heart failure, and certain cardiac rhythm disorders such as atrial fibrillation. It works by slowing the heart and reducing the workload on the cardiovascular system.
How does Metoprolol Tartrate work in the body?+
The drug selectively blocks β1‑adrenergic receptors in the heart, preventing adrenaline and noradrenaline from increasing heart rate and contractility. This leads to a lower cardiac output and reduced arterial pressure, while also decreasing the heart’s oxygen demand.
What is the usual dose of Metoprolol Tartrate?+
The appropriate dose of Metoprolol Tartrate is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any co‑existing health issues. Dosage may be adjusted over time to achieve the desired therapeutic effect.
Is Metoprolol Tartrate safe during pregnancy or breastfeeding?+
Safety data for Metoprolol Tartrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Metoprolol Tartrate from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Metoprolol Tartrate compare with other beta blockers?+
Metoprolol Tartrate is a selective β1‑blocker, offering cardiac‑focused effects with fewer bronchial side effects compared with non‑selective agents like propranolol. Its pharmacokinetic profile allows twice‑daily dosing, which can be advantageous for certain patients.
What are the recommended storage conditions for Metoprolol Tartrate?+
Metoprolol Tartrate tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children.
How is Metoprolol Tartrate administered?+
The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks associated with Metoprolol Tartrate?+
Serious risks include severe bradycardia, heart block, marked hypotension, and bronchospasm in patients with reactive airway disease. Patients should seek immediate medical attention if they experience fainting, very slow heart rate, or difficulty breathing.
Who should not use Metoprolol Tartrate?+
Metoprolol Tartrate is contraindicated in patients with known hypersensitivity to the drug, severe bradycardia, second‑ or third‑degree heart block without a pacemaker, and in those with uncompensated heart failure. Clinicians should also exercise caution in individuals with asthma or severe chronic obstructive pulmonary disease.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Metoprolol Tartrate
Route
Oral Use
Manufacturer
Generics [uk] Limited
Origin
EU

Related products